Biocompatible, surface functionalized mesoporous titania nanoparticles for intracellular imaging and anticancer drug delivery
Author(s) -
Kevin C.W. Wu,
Yusuke Yamauchi,
Chen-Yu Hong,
Ya-Huei Yang,
Yung-He Liang,
Takashi Funatsu,
Makoto Tsunoda
Publication year - 2011
Publication title -
chemical communications
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.837
H-Index - 333
eISSN - 1364-548X
pISSN - 1359-7345
DOI - 10.1039/c1cc10659g
Subject(s) - biocompatibility , doxorubicin , drug delivery , nanoparticle , biocompatible material , intracellular , chemistry , mesoporous material , nanotechnology , surface modification , drug carrier , combinatorial chemistry , biophysics , materials science , organic chemistry , biochemistry , biomedical engineering , catalysis , medicine , surgery , chemotherapy , biology
Mesoporous titania nanoparticles (MTNs) with excellent biocompatibility (LC(50)≈ 400 μg mL(-1)) and a large surface area (ca. 237.3 m(2) g(-1)) were synthesized and further functionalized with a phosphate-containing fluorescent molecule (i.e. flavin mononucleotide; FMN) and loaded with an anticancer drug (i.e. Doxorubicin) for successful intracellular bioimaging and drug delivery, respectively, in human breast cancer cells BT-20.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom